Sangamo Therapeutics Inc
NASDAQ:SGMO
Sangamo Therapeutics Inc
NASDAQ:SGMO
Price:
0.3515
USD
4.93%
Market Cap:
$125.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Sangamo Therapeutics Inc
NASDAQ:SGMO
|
US |
|
Skeena Resources Ltd
TSX:SKE
|
CA |
|
I
|
In The F Co Ltd
KRX:014990
|
KR |
Relative Value
The Relative Value of one
SGMO
stock under the Base Case scenario is
0.7694
USD.
Compared to the current market price of 0.3515 USD,
Sangamo Therapeutics Inc
is
Undervalued by 54%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SGMO
Relative Value
Base Case
0.7694
USD
Undervaluation 54%
Multiples Across Competitors
SGMO Competitors Multiples
Sangamo Therapeutics Inc Competitors
Sangamo Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Sangamo Therapeutics Inc
NASDAQ:SGMO
|
125.6m USD | 3.8 | -1.1 | -0.9 | -0.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.8B USD | 6 | 87.7 | 14.6 | 20.2 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.8B USD | 5.2 | 24.8 | 14.4 | 14.4 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.4B USD | 5.9 | 20.3 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.9B USD | 9.7 | 29.4 | 22.2 | 23.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.4B USD | 5.5 | 17.6 | 13 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD | 3.1 | 34.4 | 11.4 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
35.7B EUR | 10.4 | 33.5 | 36.3 | 37 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
